The US Department of Justice's move to reclassify medical cannabis to Schedule III could unlock critical research ...

Texas industrial hemp businesses are challenging state regulations banning smokable products and increasing licensing fees.

CAURD Inc. outlined a three-point plan to stabilize New York's equity cannabis market. This advocacy aims to refine cannabis ...

Explore how potential US federal medical cannabis reclassification could impact market dynamics, regulatory frameworks, and ...

Florida regulators have cited multi-state operator Trulieve for alleged environmental violations at a cannabis cultivation ...

The US Justice Department's recent order reclassifies medical cannabis, removing it from Schedule I. This move impacts ...

New Zealand's medicinal cannabis prescriptions surged to 44% of users in 2025, driven by clinics and online access. Explore ...

Discover how smarter, real-time clinical trials could reshape drug development, offering more efficient pathways for new ...

Explore the implications of the recent federal medical marijuana reclassification from Schedule I to Schedule III, affecting ...

Maryland's new law, effective October 1, protects firefighters and EMTs using medical cannabis off-duty. Learn how this ...

Virginia's adult-use cannabis market faces continued uncertainty after lawmakers rejected Governor Spanberger's extensive ...

Understanding the importance of defensible medical cannabis pricing data is crucial for investors and operators navigating ...